{"nct_id":"NCT01602406","title":"Phase I Study LJM716 Combined With Trastuzumab in Patients With HER2 Overexpressing Metastatic Breast or Gastric Cancer","status":"COMPLETED","status_verified_date":"2018-07","start_date":"2012-09-21","start_date_type":"ACTUAL","primary_completion_date":"2017-08-02","primary_completion_date_type":"ACTUAL","completion_date":"2017-08-02","completion_date_type":"ACTUAL","phases":["PHASE1"],"tickers":["NVS"]}